[Surgical treatment of bilateral forms of pulmonary tuberculosis].

[Videothoracosopy in diagnosis and surgical treatment of tuberculosis]. Khirurgiia (Mosk) (2002) 1.02

Direct antiviral effect of cycloferon (10-carboxymethyl-9-acridanone) against adenovirus type 6 in vitro. Antiviral Res (2003) 0.77

[Indicators of humoral immunity in rotavirus infection among various age groups of St. Petersburg residents from CFT data]. Vopr Virusol (1995) 0.76

[INFLUENCE OF ANGIOPROTECTOR DRUGS ON THE EFFICACY OF CYTOSTATIC THERAPY (EXPERIMENTAL STUDY)]. Eksp Klin Farmakol (2016) 0.75

[Protective effect of cycloferon in experimental influenza]. Vopr Virusol (2001) 0.75

[The therapeutic efficacy of cycloferon and the pharmacological activity of interferon inducers]. Ter Arkh (2014) 0.75

[Biological Functions of Succinate (a Review of Foreign Experimental Studies)]. Antibiot Khimioter (2015) 0.75

[The use of cycloferon in experimental radiotherapy of tumors]. Vopr Onkol (1999) 0.75

[Cycloferon in complex therapy management of chronic laryngitis]. Antibiot Khimioter (2013) 0.75

[Virus carriers in rotavirus infection]. Vopr Virusol (1997) 0.75

[Cycloferon efficacy of therapy of chronic hepatitis B (results of randomized multicentre study)]. Antibiot Khimioter (2010) 0.75

[Rationale of application of the drug Cytoflavin in complex treatment of patients with diabetic foot syndrome with mediacalcification arteries]. Khirurgiia (Mosk) (2014) 0.75

[Cycloferon in emergency prophylaxis of respiratory viral infections and influenza]. Klin Med (Mosk) (2011) 0.75

[Interferon inductor activity and interferon production under the action of acridonacetic acid salts]. Eksp Klin Farmakol (2014) 0.75

[Induction of type 1, 2 and 3 interferons by acridone acetates]. Antibiot Khimioter (2014) 0.75

[Effectiveness of cycloferon in treating virus-associated inflammatory gynecologic diseases]. Vopr Virusol (1999) 0.75

[Use of cytoflavin for correction of complications of myocardial infarction]. Eksp Klin Farmakol (2002) 0.75

[Cycloferon efficacy in viral and bacterial diseases of children (clinical review)]. Antibiot Khimioter (2010) 0.75

[Pathogenetic correction of metabolic disturbances in chronic liver affections]. Antibiot Khimioter (2012) 0.75

[Cycloferon in therapy of hyperplastic laryngitis for decrease of the number of relapses]. Eksp Klin Farmakol (2013) 0.75

[Effect of cycloferon on dissemination of Lewis lung carcinoma in mice and rhabdomyosarcoma ra-23 in rats]. Vopr Onkol (1999) 0.75

[Experimental study of cytoprotector effect of succinate-containing drugs on functional activity of liver]. Eksp Klin Farmakol (2010) 0.75

[Pathogenetic therapy of tuberculosis of respiratory organs during sanatorium-and-spa treatment]. Vopr Kurortol Fizioter Lech Fiz Kult (2009) 0.75

[Problems in treating influenza and acute respiratory infection in children]. Eksp Klin Farmakol (2011) 0.75

[Efficacy of antioxidant energocorreсtion in brain infarction (results of a multicenter randomized trial)]. Zh Nevrol Psikhiatr Im S S Korsakova (2014) 0.75

[Effect of succinate- and methionine-containing drug runihol on reparative regeneration processes in liver under experimental hepatectomy conditions]. Eksp Klin Farmakol (2012) 0.75

Effects of cytoflavin and neuronol on morphological changes in the brain and survival of rats with ischemic disturbances in cerebral blood flow. Bull Exp Biol Med (2004) 0.75

[Effect of cycloferon on the evolution of cervical and vaginal cancer in mice]. Vopr Onkol (2000) 0.75

[Modern methods of energy homeostasis correction in elderly patients]. Adv Gerontol (2014) 0.75

[Gerontological trends of contemporary forms of alcohol dependence. Approaches to full compensation and rehabilitation]. Adv Gerontol (2014) 0.75

[Experimental and clinicolaboratory evaluation of complex therapy efficacy in arboviral infections]. Antibiot Khimioter (2012) 0.75

[Cycloferon as an agent for the anti-relapse therapy in patients with chronic hyperplastic sinusitis]. Antibiot Khimioter (2013) 0.75

[Correction of postischemic reperfusion injury complications by cytoflavin]. Biull Eksp Biol Med (2000) 0.75

Neuroprotective effect of cytoflavin during compression injury of the spinal cord. Bull Exp Biol Med (2005) 0.75

[THE PHARMACOTHERAPEUTIC EFFICIENCY OF CYTOFLAVIN IN PATIENTS WITH DIABETIC FOOT SYNDROME: IMMEDIATE AND LONG-TERM RESULTS]. Klin Med (Mosk) (2015) 0.75

[The hepatotropic activity of runihol and ademethionine against experimental liver damage caused by first-line antituberculosis drugs]. Arkh Patol (2014) 0.75

[Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Klin Med (Mosk) (2010) 0.75

[Immunotropic and antihypoxant therapy of experimental drug-sensitive and drug-resistant tuberculosis]. Patol Fiziol Eksp Ter (2013) 0.75

[Effect of hepatoprotector remaxol infusion on liver function in obstructive jaundice model in rats]. Eksp Klin Farmakol (2010) 0.75

[Postgraduate training of pharmacists at the Kiev Institute of Physician Postgraduate Training]. Farm Zh (1973) 0.75

[Detoxicating properties of remaxol with respect to multiple organ failure during severe ethanol poisoning]. Eksp Klin Farmakol (2010) 0.75

[Effect of infusion hepatoprotectors on hepatic function in experimental cholestasis]. Khirurgiia (Mosk) (2010) 0.75

[Cycloferon, as an agent in the therapy and urgent prophylaxis of influenza and acute respiratory tract viral infection (multicentre randomized controlled comparative study)]. Antibiot Khimioter (2009) 0.75

[The influence of immunotropic drugs on reparative processes in the lungs experimental chemotherapy drug resistant tuberculosis]. Eksp Klin Farmakol (2014) 0.75

[Comparative evaluation of reamberin and mafusol on acute toxic liver damage models]. Eksp Klin Farmakol (2012) 0.75

[Molecular epidemiology of rotaviruses circulating among residents of St. Petersburg from 1986 through 1991]. Vopr Virusol (1995) 0.75

[Immunomodulator Cycloferon in the comprehensive treatment of patients with acute non-lymphoblastic leukemia]. Vopr Onkol (1999) 0.75

[Comparative study of hepatoprotective action of remaxol, reamberin and ademethionine in liver injury induced by antituberculosis drugs (experimental study)]. Antibiot Khimioter (2011) 0.75

[Efficacy of antiviral agents in the treatment of Crimean hemorrhagic fever]. Klin Med (Mosk) (2012) 0.75

[PHARMACOLOGICAL CORRECTION OF METABOLIC DISORDERS IN CHILDREN WITH ACUTE EPSTEIN--BARR VIRAL INFECTION]. Eksp Klin Farmakol (2016) 0.75

[Therapeutic efficiency of cytoflavine solution for infusion in emergency conditions]. Klin Med (Mosk) (2010) 0.75

[Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)]. Ter Arkh (2010) 0.75

[Improvement of natural resistance in children for prophylaxis of influenza and acute respiratory tract viral infections (results of multicenter randomized trials)]. Antibiot Khimioter (2009) 0.75

[Modified therapy of herpetic infection]. Klin Med (Mosk) (2011) 0.75

[Intrahepatic induction of endogenous S-adenosyl-L-methionine against the background of various ways of administration of methionine-succinate complex and its role in drug-induced liver lesion correction]. Vestn Ross Akad Med Nauk (2012) 0.75

[Combined cycloferon treatment of tuberculosis in patients infected with HIV]. Eksp Klin Farmakol (2010) 0.75

[Virus infections and interferon inducers in the complex therapy]. Antibiot Khimioter (2013) 0.75

[Neuroprotective effect of cytoflavin in closed craniocerebral trauma]. Eksp Klin Farmakol (2004) 0.75

[Free-radical oxidation and antioxidant protection by experimental cholestasis]. Khirurgiia (Mosk) (2011) 0.75

[The use of cycloferon in the therapy of experimental herpetic keratitis]. Antibiot Khimioter (2000) 0.75

[Lung cancer in tuberculosis patients]. Probl Tuberk (1982) 0.75

[Preclinical study of Reamberin and Remaxol safety]. Eksp Klin Farmakol (2010) 0.75

Inhibitory effect of synthetic interferon inductor Cycloferone on 1,2-dimethylhydrazine-induced colon carcinogenesis in rats. Cancer Lett (2000) 0.75

[Cycloferon--a new domestic preparation for the prophylaxis of influenza and other acute respiratory viral infections]. Zh Mikrobiol Epidemiol Immunobiol (2005) 0.75

[Study of detoxifying efficacy of remaxol in experimental model of cisplatin-induced toxicosis]. Eksp Klin Farmakol (2011) 0.75

[Immunomodulators in combined therapy of patients with chronic hepatitis]. Antibiot Khimioter (2011) 0.75

[The effect of cycloferon administration on the growth of transplantable tumors in rats and mice]. Vopr Onkol (1998) 0.75

[The complex energy correction of chronic brain ischemia]. Zh Nevrol Psikhiatr Im S S Korsakova (2011) 0.75

[Comparative study of remaxol and ademethionine effects on reparative regeneration processes in the liver subjected to surgical intervention]. Eksp Klin Farmakol (2011) 0.75

[Evaluation of safety and pharmacotherapeutic efficacy of cycloferon in treatment of Astrakhan rickettsial fever]. Antibiot Khimioter (2012) 0.75

[Rational pharmacotherapy and correction of immunity disorders in children with chronic hepatitis (clinical review)]. Antibiot Khimioter (2010) 0.75

[Reamberin for pathogenetic therapy of acute and chronic viral diseases of the liver]. Klin Med (Mosk) (2010) 0.75

[Cycloferon in treating duodenal ulcers in rats]. Eksp Klin Farmakol (2002) 0.75

[Up-to-date approach to treatment of inflammatory infections in the maxillofacial region]. Antibiot Khimioter (2009) 0.75

[Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection]. Antibiot Khimioter (2010) 0.75

[Correction of free radical processes by a succinic acid drug (reamberine) in intensive care of patients with acute neurotropic poisoning]. Anesteziol Reanimatol (2001) 0.75

[Cycloferon in the treatment of infectious diseases]. Antibiot Khimioter (2008) 0.75

[Correction of adverse reactions in antimicrobial therapy of respiratory tract tuberculosis]. Antibiot Khimioter (2008) 0.75

[Possibilities for the correction of immune disorders during tuberculosis infection]. Klin Med (Mosk) (2010) 0.75

[Dose-dependent interferon-induction activity and pharmacokinetics of cycloferon in healthy humans]. Eksp Klin Farmakol (2012) 0.75

[Pathogenetically substantiated therapy of patients with virus hepatitis C, quality of life, and the disease outcome risk (clinical survey)]. Antibiot Khimioter (2010) 0.75

[Metabolic therapy of nephrolithiasis in two different rat models of kidney disease]. Eksp Klin Farmakol (2015) 0.75

[Effect of antiviral drugs with various mechanisms of action on morphogenesis of infection caused by extremely pathogenic influenza virus strains in animals]. Eksp Klin Farmakol (2011) 0.75

Experimental study of biological activity of angiogen in experimental cardiovascular and hemostasis pathology. Bull Exp Biol Med (2002) 0.75

[Antiamnesic effect of cytoflavin and neuronol in rats with ischemic impairment of cerebral circulation]. Eksp Klin Farmakol (2004) 0.75

[Performance evaluation of integrated cytoprotective therapy of different duration in patients with cerebral infarction]. Eksp Klin Farmakol (2015) 0.75

[Clinical and laboratory characteristics of rotavirus infection in adults]. Vestn Ross Akad Med Nauk (1995) 0.75

[Chemotherapy of chronic viral hepatitis B: randomized multicenter investigation results]. Eksp Klin Farmakol (2010) 0.75

[Remaxol restores the liver antioxidant protection system in experimental cyclophosphan-induced injury]. Eksp Klin Farmakol (2011) 0.75

[Surgical treatment of bilateral pulmonary tuberculosis]. Probl Tuberk (1998) 0.75

[Prevention of cognitive dysfunction in patients operated on thyroid gland]. Khirurgiia (Mosk) (2011) 0.75

[A device for supporting the legs during lymphography]. Vestn Khir Im I I Grek (1989) 0.75

[On clinical manifestations of rotavirus-related gastroenteritis and possible links with its viral phoretype]. Klin Med (Mosk) (2000) 0.75

[Pathology of the middle lobe and lingular segments of the lungs based on resection data]. Probl Tuberk (1983) 0.75

[Experimental study of remaxol as a drug for supportive therapy in traditional and high-dose treatment of tumors]. Eksp Klin Farmakol (2013) 0.75

[Induction of endogenous s-adenosyl-l-methionine in hepatocytes during pharmacological correction of experimental acute toxic and chronic drug-induced liver injury]. Eksp Klin Farmakol (2011) 0.75

Effect of neuronol on lifespan and development of spontaneous tumors in SAMP-1 mice with genetically accelerated aging. Bull Exp Biol Med (2003) 0.75

[Clinical and Pathophysiological Correlations in Acute Stroke, CT Visualized at Different Times]. Antibiot Khimioter (2015) 0.75